(PRWEB) January 13, 2006
LifeCell ‘s International Symposium on Stem Cell therapy attended by about 1000 practitioners.
· Loksabha MP Ms Priya Dutt inaugurated the Symposium in Mumbai
· Dr MK Bhan Secy- Dept of Biotech was the chief guest at New Delhi
· A panel of international experts enlightened on the applications of stem cell therapy in various fields of medicine
· The Symposium was held in Chennai, Mumbai and Delhi on January 6th, 7th and 8th of 2006
January 2006: LifeCell, the pioneers in cord blood stem cell banking, announced that they would be setting up a transplant centre in Mumbai in 2007, during the ‘International Symposium on Stem Cell Therapy & Research’ with special reference to the umbilical cord blood. The international symposium was organised by LifeCell in association with Sri Ramachandra Medical College and Research Institute (SRMC & RI), for the first time in India. The rich experience of some of the best physicians and researchers in Stem Cells in the world was imparted to the medical fraternity in Chennai, Mumbai and Delhi.
Inaugurating the symposium Ms Priya Dutt said “ I have been tracking the progress of Stem Cells for many years and I strongly believe that Umbilical Cord Blood Stem Cell banking is one of the best gifts you can give your child and your family”
Mr. S. Abhaya Kumar, CEO, LifeCell said, “The response to our banking has been overwhelming from the western part of the country and base don this we have decided to set up a transplant centre in Mumbai by 2007. We are proud to have identified the potential of cord blood stem cells and to bring the modern medical breakthrough technology to this country. We continuously strive to impart knowledge and awareness on the miraculous power of Stem Cells. With the support of SRMC, we have been able to take this initiative and are grateful to the speakers for their time and guidance to the Indian medical fraternity. We are happy that over 1000 doctors benefited from this effort.”
The symposium focussed on successful stem cell transplantations including case discussions, new improvisations, technical advancements, clinical trials and approach, research presentations and regulatory standards and compliances. A panel of international experts on Cord Blood Stem Cell Banking educated the guests on stem cell therapy and research in various fields of medicine. The panel included Dr. Paul R. Sanberg, AVP, Biotechnology Development, University of South Florida; Dr. Naynesh Kamani, Professor of Pediatrics and Immunology, Children's National Medical Center, Washington; Dr. Umesh Banakar, Professor and President, Banakar Consulting Services Indianapolis; and Dr. Michael E Trigg, National Science Director-Oncology, Merck & Co., Inc., Wilmington.
Commenting on the Symposium on cord blood stem cells, Dr. Paul R. Sanberg, AVP, Biotechnology Development, University of South Florida said, “This symposium gave us an opportunity to share the knowledge and experience in the field of cord blood stem cells to the medical fraternity in India and also to assure the people of India that benefits of Stem Cells are for real and that they can also take advantage of these benefits.. This symposium was a platform for us to share some of our path breaking cases in stem cell therapy. Keeping in pace with the rapid progress in the field of Stem Cell Research and Therapy, this symposium provided a gold mine of knowledge to all the medical practitioners who are interested in this “phenomenal” world of Stem Cell therapy and stay abreast with the latest developments in this field.”
It is to be noted that LifeCell and Sri Ramachandra Medical College and Research Institute (SRMC & RI) are jointly setting up India’s First Exclusive Stem Cell Transplant Centre, in Chennai. The facility will be meant exclusively for stem cell transplants and will be conducted by experienced and renowned Stem Cell Transplant Specialists from around the world. The centre will initially focus on Haematological and Oncological ailments and expand to other areas in a phased manner.
LifeCell has also recently tied up with Saneron CCEL to launch its Indian arm, Saneron India. Saneron India will be instrumental in bringing world class Stem Cell research and therapy to people of India. Saneron India is also establishing a proprietary allogeneic bank of GMP manufactured Human Umbilical Cord Blood (HUCB) stem cell suspensions, designed for therapeutic applications for neurological and cardiac disorders.
LifeCell currently has marketing and collection centers in Chennai, Hyderabad, Bangalore, Ahmedabad, Mumbai, Allahabad, New Delhi, Kolkata and Kochi. For further information, contact LifeCell on the 24 hrs Toll free no. 1600 – 425 – 5323 or 044-5206 5716 or log on to http://www.lifecellindia.com
LifeCell, a service provided by Asia CRYO-CELL Private Ltd brings the revolutionary medical breakthrough of umbilical cord stem cell banking to India. A license agreement and knowledge-sharing tie-up with CRYO-CELL International (CCI) gives LifeCell the benefit of CCI’s expertise who are pioneers in the field of umbilical cord stem cell banking. CCI, America’s No.1 cord blood bank with the largest repository of banked samples is based at Clearwater, Florida, USA and has a track record of over 13 years. Currently, Asia CRYO-CELL, India’s first cord blood bank, has marketing and collection centers in Chennai, Hyderabad, Bangalore, Ahmedabad, Mumbai, Kolkata, New Delhi and Kochi.
Sri Ramachandra Medical Center (SRMC) is a tertiary care multi-specialty university hospital. The medical center was founded as a teaching hospital of Sri Ramachandra Medical College and Research Institute in 1985 with the intention of translating the experience and expertise in medical education into tangible affordable health care for the community. Today, SRMC is a leader in the art care for over 3000 patients who walk through its portals daily and many more who seek remote health care through its connectivity and telemedicine services.
For further information, please contact:
Ashwini / Supriya
Hanmer & Partners, Tel: 022 55524600
# # #